Characterization of the integrated filamentous phage Pf5 and its involvement in small-colony formation by Mooij, Marlies J. et al.
 
Characterization of the integrated filamentous phage Pf5 and its
involvement in small-colony formation
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Mooij, Marlies J., Eliana Drenkard, María A. Llamas, Christina
M. J. E. Vandenbroucke-Grauls, Paul H. M. Savelkoul,
Frederick M. Ausubel, and Wilbert Bitter. 2007.
“Characterization of the integrated filamentous phage Pf5 and its
involvement in small-colony formation.” Microbiology 153 (Pt
6): 1790-1798. doi:10.1099/mic.0.2006/003533-0.
http://dx.doi.org/10.1099/mic.0.2006/003533-0.
Published Version doi:10.1099/mic.0.2006/003533-0
Accessed February 19, 2015 2:44:08 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11878972
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAACharacterization of the integrated filamentous
phage Pf5 and its involvement in small-colony
formation
Marlies J. Mooij,
1 Eliana Drenkard,
2 Marı ´a A. Llamas,
1
Christina M. J. E. Vandenbroucke-Grauls,
1 Paul H. M. Savelkoul,
1
Frederick M. Ausubel
2 and Wilbert Bitter
1
Correspondence
Wilbert Bitter
w.bitter@vumc.nl
1Department of Medical Microbiology and Infection Control, VU medical centre, van der
Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
2Department of Genetics, Harvard Medical School and Department of Molecular Biology,
Massachusetts General Hospital, Boston, MA 02114, USA
Received 18 October 2006
Revised 6 February 2007
Accepted 11 February 2007
Bacteriophages play an important role in bacterial virulence and phenotypic variation. It has
been shown that filamentous bacteriophage Pf4 of Pseudomonas aeruginosa strain PAO1
mediates the formation of small-colony variants (SCVs) in biofilms. This morphology type is
associated with parameters of poor lung function in cystic fibrosis patients, and SCVs are
often more resistant to antibiotics than wild-type cells. P. aeruginosa strain PA14 also contains
a Pf1-like filamentous prophage, which is designated Pf5, and is highly homologous to Pf4.
Since P. aeruginosa PA14 produces SCVs very efficiently in biofilms grown in static cultures,
the role of Pf5 in SCV formation under these conditions was investigated. The presence of the
Pf5 replicative form in total DNA from SCVs and wild-type cells was detected, but it was not
possible to detect the Pf5 major coat protein by immunoblot analysis in PA14 SCV cultures. This
suggests that the Pf5 filamentous phage is not present at high densities in the PA14 SCVs.
Consistent with these results, we were unable to detect coaB expression in SCV cultures and
SCV colonies. The SCV variants formed under static conditions were not linked to Pf5 phage
activity, since Pf5 insertion mutants with decreased or no production of the Pf5 RF produced
SCVs as efficiently as the wild-type strain. Finally, analysis of 48 clinical P. aeruginosa isolates
showed no association between the presence of Pf1-like filamentous phages and the ability to
form SCVs under static conditions; this suggests that filamentous phages are generally not
involved in the emergence of P. aeruginosa SCVs.
INTRODUCTION
Pseudomonas aeruginosa is a versatile bacterium that can
inhabit many environments, including soil, marshes, plants
and water. In its natural environments, P. aeruginosa
predominantly grows in organized communities called
biofilms. Growth as a biofilm is also an important require-
ment for the colonization of human tissues. For instance,
P. aeruginosa grows as a biofilm in the lungs of cystic
fibrosis (CF) patients, and, despite long-term antibiotic
treatment, the lungs remain infected (Hoiby et al., 2001;
Singh et al., 2000). Recent work has indicated that
phenotypic variants (bacteria that show a stable change
in phenotype whether genetic or epigenetic), such as P.
aeruginosa SCVs, play an important role in biofilm
formation (Boles et al., 2004; Kirisits et al., 2005; Webb
et al., 2004). Moreover, hyperadherent antibiotic-resistant
SCVs also appear after treatment of P. aeruginosa PA14
cultures with the antibiotic kanamycin (Drenkard &
Ausubel, 2002).
Although the physiology and morphology of bacteria living
in biofilm and planktonic cultures appear to be completely
different, only 1% of the genes in the P. aeruginosa
strain PAO1 genome have been found to be differentially
expressed when the two types of growth are compared
(Whiteley et al., 2001). The genes that are most highly
unregulated during biofilm development (up to 83.5-fold
activation) are part of the Pf4 filamentous phage of strain
PAO1. Interestingly, Webb et al. (2004) have shown that
the production of Pf4 phage correlates with the appearance
of SCVs in PAO1 mature biofilms. Those authors found
phage filaments on the surface of SCVs isolated from
biofilms, but not on biofilm cells that had not converted to
SCVs. Moreover, wild-type planktonic cells had developed
Abbreviations: CDS, coding sequence; CF, cystic fibrosis; RF, replicative
form; SCV, small-colony variant.
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purified Pf4 virions. Because it is known that prophages
can cause DNA inversions and phenotypic variation
(Kutsukake & Iino, 1980; Tominaga, 1997), Webb et al.
(2004) concluded that Pf4 was a mediator of phase
variation in P. aeruginosa biofilms. A report by Deziel
et al. (2001) has also linked the emergence of SCVs in P.
aeruginosa strain H57RP to phase variation, based on the
observation that cells switched at high frequency from the
SCV to the wild-type phenotype. However, those authors
did not look for the association of a filamentous phage
with variant formation (Deziel et al., 2001). Other reports
have also described bacteriophages that cause or modulate
phase variation. In Escherichia coli, filamentous phage f1
infection has been linked to the appearance of small
colonies (Kuo et al., 2000), and a recent report by
Brockhurst et al. (2005) has established that the ssRNA
bacteriophage PP7 modulates P. aeruginosa colony mor-
phology. Small rough, and large diffuse, colonies have been
observed in the presence of PP7 phage, whereas only large
diffuse colonies are displayed in its absence (Brockhurst
et al. 2005).
In contrast to the data reported by Whiteley et al. (2001)
and Webb et al. (2004), suggesting a role of Pf4 in SCV and
biofilm formation, transcriptional profiling of SCVs
obtained from PAO1 biofilms has shown that Pf4 phage
genes are among the most highly downregulated (up to
220-fold reduction with respect to the wild-type) in com-
parison with planktonic cells (Kirisits et al., 2005).
However, the conditions used to grow SCV cultures for
transcriptional profiling in the latter study differed con-
siderably from conditions generally used to grow biofilms,
making it difficult to directly compare the Whiteley et al.
(2001) and Kirisits et al. (2005) studies. Moreover, it is
possible that filamentous phages are important in initiating
the formation of SCVs, but not in maintaining the SCV
phenotype.
The aim of the present study was to investigate whether
Pf1-like bacteriophages are generally involved in small-
colony formation in P. aeruginosa. To address this question,
we focused on the relationship between SCVs produced by
P. aeruginosa strain PA14, and the presence of a Pf1-like
filamentous bacteriophage in the PA14 genome. In addi-
tion, we examined the occurrence of Pf1-like bacterio-
phages in P. aeruginosa clinical isolates, and their
correlation with SCV appearance.
METHODS
Bacterial strains and culture conditions. Bacterial strains and
plasmids used in this study are listed in Table 1. Clinical isolates
and primary plates were obtained from the VU medical centre
(Amsterdam, The Netherlands); clinical biofilm-related isolates
(obtained from urine catheters, and from sputa of CF patients) were
obtained from the Public Health Laboratory Friesland (Leeuwarden,
The Netherlands), and from the Universite Libre de Bruxelles
(Brussels, Belgium). Unique identifiers (mutantID) for all the
transposon mutants used in this study are listed in Table 1; further
information on these mutants can be found at http://ausubellab.
mgh.harvard.edu/cgi-bin/pa14/home.cgi. Batch cultures were routi-
nely grown in liquid Luria–Bertani (LB) medium at 37uC on a rotary
shaker operated at 200 r.p.m., unless stated otherwise. When required,
antibiotics were used at a final concentration of: ampicillin, 100 mg
ml
21; tetracycline, 20 mgm l
21; and chloramphenicol, 30 mgm l
21.
Static culture experiments were performed by inoculating individual
colonies in 3 ml LB medium. Cultures were grown vertically in test
tubes at 37uC. At each time point, the top layer of the culture
(pellicle) was taken with a swab, and resuspended in PBS solution.
Dilution series were plated onto LB agar. The first time point was
3 days. In cases where no SCVs were observed, second and third time
points were 4 and 5 days, respectively.
In SCV-induction experiments, strains were grown in LB, CAS
(Llamas et al., 2006), and M9 minimal medium (Liberati et al., 2006;
Sambrook et al., 1989), with citrate as the carbon source. Late-
exponential-phase broth cultures were supplemented with 10mM
MgSO4.
Recombinant DNA techniques. Recombinant DNA techniques
were performed as described by Sambrook et al. (1989). Total DNA
and plasmid DNA were prepared using Qiagen reagents. Restriction
endonucleases and T4 DNA ligase (New England BioLabs) were used
according to the manufacturer’s recommendations. PCR was carried
out using materials from Applied Biosystems, or using the Expand
High Fidelity PCR System (Boehringer Mannheim) for cloning
purposes. PCRs were performed using 1 ng template DNA ml
21,
200 mM each dNTP, 0.5 mM each primer, and 5% (v/v) DMSO (final
concentration). DNA was extracted from gels using a Qiagen gel
extraction kit. Sequencing analysis was performed with the BigDye
terminator v3.1 cycle sequencing kit (Applied Biosystems) on an ABI
Prism 3100 capillary sequencer (Applied Biosystems), according to
the manufacturer’s specifications.
Computer-assisted analysis. The genome of P. aeruginosa strain
PA14 was analysed for the presence of a Pf4-like phage with KODON
version 2.03 (Applied Maths). This program was also used to predict
the repeat region of the Pf4-like phage.
Western immunoblot analysis. P. aeruginosa wild-type and SCV
cells were grown overnight with agitation, and harvested by centri-
fugation (5 min, 25000 g). Prior to the centrifugation, SCV cultures
were plated to confirm that the bacteria had preserved their pheno-
type. Bacterial pellets were resuspended in sonication buffer contain-
ing 20 mM Tris/HCl (pH 8.0) and 5 mM EDTA. After ultrasonic
disruption of the cells, cell envelope proteins were isolated by
centrifugation (5 min, 25000 g). Prior to loading the gel, the samples
were incubated for 10 min at 95uC. Total proteins were subjected to
three-layer SDS-PAGE. In short, the stacking gel was 4% (w/v)
acrylamide combined with 10% (w/v) (approx. 1 cm) and 15% (w/v)
acrylamide separating gels containing 0.13% (v/v) glycerol. The
protein bands were blotted to a Hybond nitrocellulose membrane
(Amersham Biosciences), and were probed with either rabbit poly-
clonal antiserum against phage Pf1 (1:250), or pre-immune serum
obtained from the same rabbit (Asla Biotech). Two plasmids, one
containing the gene encoding the major coat protein (coaB) of Pf4,
and the other containing coaB of Pf5, both under the control of the
Plac promoter, were used as positive controls. coaB-Pf4 was amplified
with primers CoaB-F 59-TTTAAGCTTCGTCACTTCTTCGTAAAG-
CC-39 (bp 790948–790967) and PA724R 59-GGCCTTGACGCA-
GGTAGTTC-39 (bp 792071–792052), which were based on the
sequence GenBank accession no. AE0040921.2. Subsequently, coaB-
Pf4 was cloned into a pCR II-TOPO vector (Invitrogen), according to
the manufacturer’s recommendations. coaB-Pf5 was amplified with
primers CoaB-F 59-TTTAAGCTTCGTCACTTCTTCGTAAAGCC-39
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ACAACACCAGC-39 (bp 602542–602524), which were based on
the sequence GenBank accession no. NZ_AABQ07000002. The
forward primer contains a HindIII restriction site, and the reverse
primer contains a PstI restriction site (restriction sites are underlined
in the respective primer sequences). The PstI site was not used in
subsequent cloning. The coaB-Pf5 PCR product obtained was cloned
as a HindIII–EcoRI (the EcoRI site was present in the CoaB fragment)
fragment into the polylinker of the pUC19 plasmid. coaB-Pf4 and
coaB-Pf5 constructs were transformed into E. coli XL10 competent
cells, and the presence of coaB was confirmed by DNA sequencing.
Overnight LB broth cultures of XL10 cells containing the Pf5 or Pf4
coaB-expressing plasmids were supplemented with 1 mM IPTG for
3 h prior to protein isolation.
coaB promoter activity analysis. Two transcriptional fusions of
the region upstream of the major coat protein of phage Pf5 (coaB)
were made using the pMP220 plasmid, which contains a promoterless
lacZ gene (Spaink et al., 1987). Specific primers TCoaB-F 59-
AAGAATTCGGCTTGTCAGATTACACTGGG-39 (bp 599183–599203)
and TCoaB-R 59-AATCTAGAGGACATATCACCCTTGCCC-39
(bp 602230–602212) were designed based on the sequence Gen-
Bank accession no. NZ_AABQ07000002, and PfTF-F 59-AAGAAT-
TCGAGACGACGTTGCGATAGG-39 (bp 789959–789977) and
PfTF-R 59-AATCTAGACCACAGTTCGACGACGCC-39 (bp 790206–
790190) were designed based on the sequence GenBank acces-
sion no. AE004091. Both of the PCR products were cloned as
EcoRI–XbaI fragments (restriction sites are underlined in primer
sequences) into the EcoRI–XbaI sites of pMP220, and transformed
into DH5a. The fusion constructs were confirmed by DNA
sequencing, and eventually transferred to P. aeruginosa PA14 by
triparental mating using E. coli strain HB101 (pRK600) as the
helper strain (de Lorenzo & Timmis, 1994). The SCVs used for
this assay were obtained using static culture conditions, and then
directly recultured in LB broth with agitation (overnight). Cells
were checked for lack of reversion to wild-type phenotype after
culturing. b-Galactosidase assay activity from the transcriptional
fusion construct was measured as described by Miller (1972). Each
assay was run in duplicate at least three times.
SCV induction experiments. Supernatants from late-exponential-
phase LB cultures of fresh SCV and wild-type colonies were used to
incubate wild-type cells (diluted 300 times), and look for emergence
of SCVs. The supernatants were diluted 1:2 with fresh medium to
supply fresh nutrients to the bacteria, and then filter-sterilized prior
to use. All culture incubations were carried out at 37uC on a rotary
shaker operated at 200 r.p.m. Different dilutions of the cultures were
plated on LB medium after 1, 3 and 5 days post-incubation. Induction
experiments were repeated five times in LB medium, and performed
one time each in CAS broth and M9 minimal medium.
Detection of the Pf5 replicative form. To detect the presence of the
Pf5 replicative form (RF), and to accurately define Pf5 boundaries
within the P. aeruginosa PA14 genome, we generated primers
Table 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristics Reference
E. coli
DH5a supE44 DlacU169 (w80 lacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Hanahan (1983)
HB101 supE44 hsdS20 recA13 ara-14 proA2 lacY1 galK2 rpsL20 xyl-5 mtl-1 Boyer & Roulland-
Dussoix (1969)
P. aeruginosa
PA14 Wild-type Rahme et al. (1995)
PA14_49000 Single transposon insertion in PA14_49000 using the MAR2xT7,G m
r (mutantID 28588) Liberati et al. (2006)
PA14_48990 Single transposon insertion in PA14_48990 using the MAR2xT7,G m
r (mutantID 24025) Liberati et al. (2006)
PA14_48970 Single transposon insertion in PA14_48970 using the MAR2xT7,G m
r (mutantID 25542) Liberati et al. (2006)
PA14_48940 Single transposon insertion in PA14_48940 using the MAR2xT7,G m
r (mutantID 25468) Liberati et al. (2006)
PA14_48930 Single transposon insertion in PA14_48930 using the MAR2xT7,G m
r (mutantID 36387) Liberati et al. (2006)
PA14_48920 Single transposon insertion in PA14_48920 using the MAR2xT7,G m
r (mutantID 25825) Liberati et al. (2006)
PA14_48910 Single transposon insertion in PA14_48910 using the MAR2xT7,G m
r (mutantID 33859) Liberati et al. (2006)
PA14_48890 Single transposon insertion in PA14_48890 using the MAR2xT7,G m
r (mutantID 41135) Liberati et al. (2006)
PA14_48880 Single transposon insertion in PA14_48880 using the MAR2xT7,G m
r (mutantID 37556) Liberati et al. (2006)
Plasmids
pUC19 Cloning vector with oriColE1, rop mutant, a-lacZ mutant Lin-Chao et al. (1992)
pRK600 Helper plasmid with oriColE1, mobRK2 and traRK2;C m
r de Lorenzo & Timmis
(1994)
pMP220 IncP broad-host-range lacZ fusion vector; Tc
r Spaink et al. (1987)
pMPPcoaB CoaB promoter fragment cloned upstream of lacZ gene in pMP220; Tc
r This study
pMMB67EH IncQ broad-host-range plasmid; lacI
q Ap
r Furste et al. (1986)
pMMBPf5c pMMB67EH carrying the SacI–XbaI Pf5 fragment subcloned from TOPO II vector in the
opposite orientation with respect to Ptac
This study
pMMB717-720 pMMB67EH carrying the KpnI–XbaI Pf5 fragment subcloned from pCR II-TOPO in the
opposite orientation with respect to Ptac fragment
This study
pMMB727-728 pMMB67EH carrying the NheI–KpnI Pf5 fragment subcloned from TOPO II vector in the
opposite orientation with respect to Ptac
This study
pCoaB Pf4 CoaB Pf4 PCR fragment cloned into pCR II-TOPO upstream of Plac This study
pCoaB Pf5 CoaB Pf5 PCR cloned into pUC19 upstream of Plac This study
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the Pf5 RF. Primers Pf5RF-F 59-ACGGTGGAAACATCCTGGC–39
(bp 607816–607834) and Pf5RF-R 59-AACAGTGAATTGCGGA-
CAAGG-39 (bp 597865–597845) (GenBank accession no. NZ_AAB-
Q07000002) were used for this purpose. PCR amplifications were
performed using total DNA, as well as plasmid DNA (Plasmid Midi
kit; Qiagen). The PCR products obtained were cloned into a pCR II-
TOPO vector, according to the manufacturer’s recommendations,
and they were subsequently sequenced.
Complementation analysis. Pf5 Mar2xT7 transposon insertion
mutants (Table 1) were complemented with a fragment that included
the complete Pf5 phage genome, except for the flanking repeats used
in RF circularization, and the gene encoding the putative phage
regulatory protein (PA14_49030). Primers c-Pf5F 59-CAACAAT-
TCGACCTATTGCGGG-39 (bp 599555–599576) and c-Pf5R 59-
GCAAAGGAAAAATCTAGGACGTCTCG-39 (bp 607989–607964)
(GenBank accession no. NZ_AABQ07000002) were used for this
purpose. The PCR reaction was performed using the Extensor Hi-
Fidelity PCR master mix (Abgene), according to the manufacturer’s
recommendations. The 8.4 kb PCR product was cloned into a pCR II-
TOPO vector (pCR II-TOPO Pf5; Invitrogen), and subcloned into the
SacI–XbaI sites of the broad-host-range plasmid pMMB67EH with
the Ptac promoter in the opposite orientation, generating plasmid
pMMBpf5c. For the second and third constructs, the 2.8 kb KpnI–
XbaI fragment and the 2.5 kb NheI–KpnI fragment of pCR II-TOPO
pf5 were subcloned into the KpnI–XbaI sites of pMMB67EH,
generating pMMB717-720 and pMMB727-728, respectively. The
three constructs were transferred from E. coli DH5a to P. aeruginosa
by triparental mating using E. coli strain HB101 (pRK600) as a helper
strain (de Lorenzo & Timmis, 1994).
SCV quantification in Pf5 transposon insertion mutant strains.
Quantification ofSCVsintransposon mutants (PA14_49000::Mr2xT7,
PA14_48970::Mr2xT7, PA14_48890::Mr2xT7 and PA14_48880::
Mr2xT7) was performed after inoculating approximately 2.5610
8
bacteria from overnight cultures into glass tubes containing 5 ml
fresh LB medium. Then, we incubated the tubes at 37uC under
static conditions for 26 h. At that point, the samples were
removed from the incubator, and vortexed vigorously. We then
removed 1 ml aliquots from the tubes, and used gentle sonication
to dissolve bacterial aggregates completely. Serial dilutions of soni-
cated cultures were made using PBS, and the dilutions were plated
on LB agar plates. SCV and wild-type bacterial colonies were
counted using a Leica Wild M3C microscope. We calculated ratios
of SCV and wild-type colonies for each dilution plated. Mean
values and standard deviations were calculated using data from at
least three independent experiments.
Prevalence of SCVs and Pf1-like filamentous bacteriophages
in P. aeruginosa clinical isolates. Primary plates of 102 P.
aeruginosa clinical specimens were screened for the presence of SCVs.
The presence of the three Pf1-like bacteriophages (Pf1, Pf4 and Pf5)
was analysed by performing PCR amplifications in 46 biofilm-related
clinical isolates, using primers designed to specifically detect each
phage. We also used a universal primer pair designed based on the
sequence of a conserved gene that is present in all three phage
genomes (designated ORF424 in Pf1, PA0726 in PAO1, and
PA14_48910 in Pf5), and which corresponds to a predicted Zot-
toxin-like gene. Pf1-specific primers Pf1-F 59-CTATGAGAATGG-
TCGTTCCG-39 (bp 5734–5753) and Pf1-R 59-CAGAAGATCGACT-
TGCCC-39 (bp 6284–6267), Pf4-specific primers Pf4-F 59-TCGAA-
TTCCGCTTCCATCAC-39 (bp 795297–795317) and Pf4-R 59-
CCTGATGCTTGGTCAGGTACG-39 (bp 796297–796277), and Pf5-
specific primers Pf5-F 59-ATTCACCGAGCTTCGTAGGC-39
(bp 607 355–607 374) and Pf5-R 59-GCGGTATCGTATTGCCAA-
GAG-39 (bp 607764–607744) were designed based on sequences
obtained from GenBank (accession nos X52107, NC_002516 and
NZ_AABQ07000002, respectively). Universal Pf1-like phage primers
pfU-F 59-GTGTCGATCAAGATCCACCA-39 (bp 604150–604169)
and pfU-R 59-GGAGGAAGAAAGCTATTCGCA-39 (bp 605 021–
605 001) were designed based on the PA14 strain sequence
(GenBank accession no. NZ_AABQ07000002). The amplification of
the universal Pf1-like phage PCR was combined with the Pf4-specific
PCR, in which an annealing temperature of 53uC was used.
RESULTS AND DISCUSSION
PA14 Pf1-like filamentous bacteriophage
Genome analysis of P. aeruginosa PA14 revealed the pres-
ence of a Pf1-like filamentous prophage, which we named
Pf5. The genes of Pf5 show conserved synteny and high
identity with those of filamentous bacteriophage Pf4 and,
to a lesser extent, with those of phage Pf1 (Fig. 1). A major
difference between Pf5 and Pf4 is the absence of four Pf4-
coding sequences in Pf5 (Table 2). These additional coding
sequences (CDSs) encode a putative reverse transcriptase
Fig. 1. Comparison of the Pf5 genome with the genomes of Pf1 and Pf4. The designations below the Pf4 genome correspond
to gene names from the PAO1 genome sequence (Stover et al., 2000). For corresponding designations in Pf1 and PF5, see Hill
et al. (1991) and Table 2 (this study), respectively. Only additional CDSs present in Pf5 compared with Pf4 are depicted. The
black dotted lines indicate regions used to detect the promoter activity of coaB.
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(PA0716), a putative prevent-host-death (phd) antitoxin
protein (intergenic region between PA0728 and PA0729),
and a plasmid stabilization toxin protein of the RelE/ParE
family (PA0729) (Webb et al., 2004; Table 2). In addition,
there are three additional CDSs in Pf5 that encode a
putative phage regulatory protein (PA14_49030) and two
proteins of unknown function (PA14_49010 and PA14_
49020) (Fig. 1, Table 2). Another important difference
between Pf4 and Pf5 is the chromosomal location of the
integrated bacteriophage genomes. Phage Pf4 is located
between PA0714 and PA0730, and Pf5 is inserted between
the PA14 homologues of the PAO1 PA1191 (PA14_49040)
and PA1192 (PA14_48870) genes. Therefore, genome data
show that although Pf1-like bacteriophages are present in
both PAO1 and PA14 strains they are fairly diverse, and
could play different roles in their respective bacterial hosts.
In silico analysis of the Pf5 genome showed the presence of
a 10 bp direct repeat (TTTGTGCGTA) located in inter-
genic regions downstream of PA14_49040 (PAO1 PA1191
homologue) and upstream PA14_48870 (PAO1 PA1192
homologue). To detect the presence of the RF of Pf5, and
to determine the region of recircularization of the fila-
mentous phage, we designed primers directed toward
opposite ends of the putative integrated bacteriophage. A
715 bp DNA fragment was amplified using primers Pf5RF-
F and Pf5RF-R from SCVs and wild-type total DNA.
Sequence analysis of the fragments obtained showed that
phage Pf5 indeed used the 10 bp direct repeats identified
by in silico analysis to circularize. Based on the flanking
regions of the phage genome, the size of the viral genome is
10 675 bp. The size of phage Pf5 is intermediate between
the sizes of the viral genomes of Pf1 and Pf4, which are
7349 and 12 437 bp, respectively.
Emergence of SCVs in PA14
The filamentous bacteriophage Pf4 has been associated
with the formation of SCVs in P. aeruginosa strain PAO1
(Webb et al., 2004). Therefore, we studied the effect of Pf5
on SCV formation in P. aeruginosa PA14. First, the ability
of PA14 to form SCVs on biofilms formed on the air–
liquid interface of cultures incubated under static condi-
tions was studied. After 3 days’ incubation, approximately
70% of all colonies in the air–liquid interface biofilm
showed an SCV phenotype (Fig. 2). Subsequently, we
tested whether incubation of wild-type PA14 bacteria with
PA14 SCV supernatants (which potentially contain the Pf5
phage) was able to induce the emergence of SCVs, as
shown for PAO1 by Webb et al. (2004). Although
approximately 10% of wild-type cells were converted to
SCVs by the addition of SCV supernatants, this effect was
not specific for the supernatant of SCVs, since identical
results were obtained when the supernatant of wild-type
cells was used. Moreover, PA14 SCVs did not contain
superinfective phages able to form lytic plaques on PA14
wild-type bacteria (data not shown), unlike the SCVs
described by Webb et al. (2004).
Table 2. Name and function of Pf5 genes (strain PA14) and corresponding genes in Pf4 (strain
PAO1)
Pf5 (PA14) Pf4 (PAO1) Gene product
PA14_49030 No homologue Putative regulatory protein
PA14_49020 No homologue Hypothetical
PA14_49010 No homologue Hypothetical
No homologue PA0715 Putative reverse transcriptase
No homologue PA0716 Component of ABC transporter
Pa14_49000 PA0717 Hypothetical
Pa14_48990 PA0718 Hypothetical
Pa14_48980 PA0719 Hypothetical
Pa14_48970 PA0720 Helix-destabilizing protein
Pa14_48960 PA0721 Hypothetical
Pa14_48950 PA0722 Hypothetical
Pa14_48940 PA0723 Coat protein B
Pa14_48930 PA0724 Putative coat protein A
Pa14_48920 PA0725 Hypothetical
Pa14_48910 PA0726 Hypothetical
Pa14_48890 PA0727 Hypothetical
Pa14_48880 PA0728 Probable bacteriophage integrase
No homologue Intergenic region between
PA0728 and PA0729
Putative prevent-host-death (phd) antitoxin
protein
No homologue PA0729 Plasmid stabilization toxin protein
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wild-type and SCV bacteria
Although we detected the production of the RF of Pf5 by
PCR, we found no indication that Pf5 phage was responsi-
ble for the emergence of the SCVs under static conditions.
To determine whether Pf5 phages were produced by SCVs,
we used a polyclonal antibody directed against filamentous
phage Pf1 in immunoblot experiments. In addition, we also
determined whether Pf4 phages were produced by wild-
type cells and SCVs of strain PAO1. Because the antibody
used in our experiments was directed against Pf1, we tested
the specificity of the Pf1 antiserum against Pf4 and Pf5 coat
protein B by cloning and expressing the Pf4 and Pf5 coaB
genes in E. coli. We were able to detect a protein band of
8 kDa (corresponding to the size of the CoaB protein)
using both constructs when we used the Pf1 antiserum,
but not when we used the pre-immune serum (Fig. 3). In
immunoblots performed using cultures from PA14 SCVs
and wild-type bacteria (see Methods), we were unable to
detect the Pf5 CoaB protein (Fig. 3). In addition, cultures
from PAO1 wild-type cells and PAO1 SCVs obtained using
static conditions were also tested in immunoblots using Pf1
antiserum, and, again, we were unable to detect the major
coat Pf4 protein on PAO1 samples. This suggests that the
CoaB protein is not produced at detectable levels by either
wild-type cells or static SVCs in either the PAO1 or the
PA14 strain (Fig. 3). Results obtained with two PA14
mutants that contain transposon insertions in coaB
(PA14_48940) and the putative bacteriophage integrase
(PA14_48880, which does not produce the Pf5 replicative
form) showed that the high-molecular-mass band present
in the Western blot was due to a non-specific reaction with
the Pf1 antiserum (Fig. 3). The results obtained with the
PAO1 strain were somewhat unexpected, since Webb et al.
(2004) showed expression of Pf4 phage protein in PAO1
SCVs obtained from biofilms. Therefore, our results
suggest that formation of small colonies in P. aeruginosa
is likely to involve other mechanisms in addition to the
production of filamentous bacteriophages.
To confirm that the CoaB protein is not produced at
detectable levels in PA14 bacteria, we analysed the pro-
moter activity of the gene encoding the major coat protein
(coaB) of Pf5 in both wild-type cells and SCVs. We cloned
two different PCR fragments, both of which contained the
putative promoter region of PA14 coaB (Fig. 1, dotted
lines) upstream of a promoterless lacZ reporter gene of
pMP220, and introduced the construct in P. aeruginosa
PA14. The results obtained showed no expression of coaB
in either the SCVs or the wild-type cells of PA14, sug-
gesting that Pf5 coaB is not expressed at detectable levels.
As a control, we plated SCV colonies containing the lacZ
reporter directly on medium supplemented with X-Gal.
None of the SCVs plated showed observable b-galactosi-
dase activity. Together, these results show that coaB is not
expressed above background levels in P. aeruginosa PA14,
independent of the colony phenotype.
Fig. 2. Wild-type (WT) colonies and SCVs derived from a 3-day-
old static liquid culture of PA14.
Fig. 3. Immunoblot analysis using Pf1 anti-
serum. (a) Cell envelope proteins (b) Secreted
proteins. PA14_48940::MR2xT7 is a coaB
mutant, and PA14_48880::MR2xT7 is a RF
mutant. Total protein from XL10 E. coli cells,
complemented with different constructs, was
used as a control in (a) and (b).
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The results presented so far suggest that Pf5 is not involved
in the emergence of PA14 SCVs in biofilms gown under
static conditions. In order to show this unequivocally, we
analysed nine transposon insertion mutants in the Pf5
region (Table 1). We first extracted total DNA from the
transposon mutants, and looked for the presence of the
Pf5 RF by PCR, using primers Pf5RF-F and Pf5RF-R. As
shown in Fig. 4(a), four transposon insertion mutants
(PA14_49000::Mr2xT7, PA14_48970::Mr2xT7, PA14_
48890::Mr2xT7 and PA14_48880::Mr2xT7) consistently
showed no PCR product corresponding to the Pf5 RF. Two
of the mutants that showed absence of the RF PCR product
have transposon insertions in genes involved in bacterio-
phage replication. Mutant PA14_48970::Mr2xT7 contains
the insertion in a gene encoding a Pf1 single-stranded
DNA-binding protein homologue responsible for the for-
mation of a pre-assembly complex with the viral DNA, and
the insertion in mutant PA14_48880::Mr2xT7 is located in
a gene encoding a putative phage integrase (PA14_48880).
We were unable to detect the major coat protein in cultures
from the mutant PA14_48880::Mr2xT7 using Pf1 anti-
serum (Fig. 3). The other two mutants contain insertions
in the PA14_49000 and PA14_48890 CDSs that encode two
hypothetical proteins of 70 and 432 aa, respectively. A
BLAST search of the proteins encoded by these genes showed
a high degree of homology to Pseudomonas Pf1 and Pf4
proteins (Hill et al., 1991; Webb et al., 2004). Moreover,
the protein encoded by PA14_48890 also showed 46%
similarity to a replication initiation factor from Geobacter
metallireducens.
In order to confirm that the genes PA14_49000, PA14_
48970, PA14_48890 and PA14_48880 are involved in the
production of the RF, we tested whether plasmid
pMMBpf5c, which contains most of the Pf5 genome
(except for the repeat regions and the putative phage
regulator gene PA14_49030), could complement the four
insertion mutants. However, this plasmid did not comple-
ment the RF phenotype in any of the mutants (Fig. 4b).
The expression of the Pf5 genes from a medium-copy-
number plasmid could have a negative effect on the pro-
duction of the RF, although this was not evident when
pMMBpf5c was introduced into the wild-type strain. We
made two new constructs with shorter regions of the Pf5
genome, and used them to complement the mutants.
One of these plasmids (pMMB727-728) contained the
PA14_48890 and PA14_48880 genes, and the other
(pMMB717-720) contained a total of 12 genes, including
genes PA14_48940 (coaB)–PA14_49050 (downstream of
the PA14_49030 phage regulator). As shown in Fig. 4(b),
mutant PA14_48880 (putative integrase) could be com-
plemented with plasmid pMMB727-728, showing that
PA14_48880 is indeed involved in RF production. Com-
plementation of PA14_48890 with the same plasmid
(pMMB727-728) was less clear, as only very small amounts
of the RF were detected by PCR (Fig. 4b). Expression of
plasmid pMMB717-720 in PA14 wild-type prevented RF
production (Fig. 4b), and this indicates that this construct
contains a gene that represses RF production. Not surpris-
ingly, plasmid pMMB717-720 did not complement mutants
PA14_49000::Mr2xT7andPA14_48970::Mr2xT7(Fig.4b).
Since the four genes identified in Pf5 that are potentially
involved in RF production have homologues in PAO1
Pf4, it would be interesting to test PAO1 mutants in those
particular genes, in order to confirm the involvement of
Pf4 phage in SCV formation in strain PAO1.
Subsequently, we examined the ability of the mutants
that failed to produce Pf5 RF (PA14_49000::Mr2xT7,
PA14_48970::Mr2xT7, PA14_48890::Mr2xT7 and PA14_
48880::Mr2xT7) to generate SCVs under static conditions.
Results obtained on the emergence of PA14 SCVs under
static conditions have shown that SCVs can be consistently
Fig. 4. Detection of the Pf5 RF by agar gel
electrophoresis. (a) PCR products obtained
from Pf5 transposon mutants. (b) Comple-
mentation of Pf5 transposon mutants showing
decreased RF production with plasmids
pMMB67EH (1), pMMBpf5c (2), pMMB717-
720 (3) and pMMB727-728 (4). Marker sizes
(M) are shown in base pairs.
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numbers of wild-type bacteria (E. Drenkard and F. M.
Ausubel, unpublished data). Mutant analysis performed
using the Pf5 transposon insertion mutants showed no
significant differences in the number of SCVs that emerged
at the end of the incubation period (26 h) between any of
the mutants tested and the wild-type strain. Moreover, no
morphological differences were observed when comparing
SCV colonies formed by the mutants and wild-type bacteria.
These results unambiguously demonstrate that, unlike what
was reported previously for strain PAO1, there is no link
between emergence of SCVs and Pf1-like phage activity in P.
aeruginosa strain PA14 under the conditions used.
Prevalence of SCVs and Pf1-like bacteriophages
in clinical specimens
Pf1-like filamentous phages have now been found in three
P. aeruginosa isolates (Hill et al., 1991; Webb et al., 2004).
To determine the prevalence of SCVs in clinical specimens,
102 primary plates containing P. aeruginosa colony isolates
obtained directly from patient samples (i.e. blood, sputum,
urine, and wound material) were analysed for SCVs. Only
two of the primary plates analysed showed colonies with an
SCV phenotype (ear infection, and sputum from a CF
patient). These data show that SCVs are not very common
among clinical samples, but their presence may be more
common in certain infection sites, such as the respiratory
tract of CF patients, that provide a niche for highly adher-
ent P. aeruginosa SCVs (Ha ¨ussler et al., 2003). Although
the prevalence of isolates producing SCVs is low, it does
not rule out the possibility that these strains are capable of
forming small colonies. Therefore, we checked 48 clinical
biofilm-related isolates, i.e. P. aeruginosa isolated from
urine catheters and sputa of CF patients, for their ability to
form SCVs. Upon static culturing of these P. aeruginosa
isolates, 27% formed SCVs (Table 3), and this indicates
that a reasonable number of P. aeruginosa clinical isolates
have the ability to form SCVs under these conditions.
Because some P. aeruginosa strains, such as strain PAO1,
form SCVs at very low frequencies under static conditions
(0.024% of PAO1 colonies were SCVs after 65 h incuba-
tion, compared with 76% for strain PA14), it is possible
that we have underestimated the number of clinical isolates
able to form SCVs in the present study. Subsequently, we
tested the 48 biofilm-related isolates for the presence of the
three known Pf1-like filamentous bacteriophages (Pf1, Pf4
and Pf5) by PCR amplification. First, the quality of the
genomic DNA isolated from the different isolates was tested
using PCR primers that target the P. aeruginosa PAO1
housekeeping gene PA2968 (fabD), which was detected in
all clinical isolates (data not shown). Subsequently, we
performed PCR reactions using primer pairs specific for
each of the three Pseudomonas phages, and one PCR
reaction that targeted all three phages by using a universal
primer pair (see Methods) that was designed based on the
sequence of a CDS common to Pf1, Pf4 and Pf5 (PA14_
48910). Phage Pf1 ORF100 and ORF90 (Hill et al., 1991)
were used as the targets for the Pf1-specific PCR, PA0727
and PA0728 (Webb et al., 2004) were use for the Pf4-
specific PCR, and the putative integrase gene of Pf5
(PA14_48880) was used for the Pf5-specific PCR. These
experiments showed that six isolates showed PCR ampli-
fication with the Pf4-specific primers, two isolates were
positive in the Pf5-specific PCR, and none were positive in
the Pf1-specific PCR (Table 3). The universal Pf1-like
primers amplified specific PCR products from 26 isolates,
and five of these were positive for either Pf4 or Pf5
(Table 3). This shows that, although filamentous phages
are common among clinical P. aeruginosa isolates, they
seem to be very diverse. This result is in agreement with
whole-genome DNA microarray data obtained by
Wolfgang et al. (2003), who showed that among 18 clinical
and environmental P. aeruginosa strains, different isolates
contain different subsets of the filamentous phage Pf4
genes. Comparison of the PCR data with the ability to form
SCVs showed that only 9 of the 29 clinical isolates that had
amplification products for at least one of the filamentous
phages tested produced SCVs (Table 3). These results
suggest that filamentous phages are generally not involved
in the emergence of P. aeruginosa SCVs, and this is
consistent with the data obtained using the PA14 strain
In summary, this study identified a Pf1-like filamentous
bacteriophage in the genome of P. aeruginosa strain PA14,
and it was named Pf5. Since strain PA14 forms SCVs very
efficiently, we investigated the involvement of the Pf5
filamentous phage in SCV formation. We amplified a
fragment that corresponds to the RF of Pf5 using DNA
preparations from SCVs and wild-type cells, but we did not
observe production of phage virions under the assay
Table 3. Association between the presence of Pf-like genes, as detected by PCR, and the ability to form SCVs in biofilm-related
clinical isolates
SCV phenotype Pf1-specific Pf4-specific Pf5-specific Only Pf universal* No Pf product Total
Positive 0 2 [2]D 1 [1]D 6 4 13 (27%)
Negative 0 4 [2]D 1 [0]D 15 15 35 (73%)
Total 0 (0%) 6 (12%) 2 (4%) 21 (44%) 19 (40%) 48
*Positive in the Pf-universal PCR only.
DValues in square brackets indicate the number of isolates that were also positive for the Pf-universal PCR.
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major coat protein of phage Pf4 and Pf5 (CoaB) by
Western immunoblot analysis using PAO1 and PA14 SCV
cultures, suggesting that the filamentous phages are not
present in high amounts in SCVs from strain PAO1 and
PA14. Consistent withthese results, measurements of activity
ofthecoaB genepromoterinstrainPA14didnotdetectlevels
ofcoaBexpressioninSCVculturesandSCVcolonies.Finally,
we showed that Pf5-insertion-mutant strains with decreased
or no production of the Pf5 RF produced SCVs as efficiently
as the wild-type strain, clearly demonstrating that variant
formation under static conditions is not linked to Pf5 phage
activity in P. aeruginosa strain PA14. Results obtained using
48clinicalbiofilm-relatedisolatessuggestthatthepresenceof
bacteriophages of the Pf family does not correlate with the
ability of the bacterial host to form SCVs under static
conditions in P. aeruginosa.
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